Targeted therapeutics are a new type of anti-cancer drug that impedes cancer growth by blocking specific molecules that promote cancer. Unlike chemotherapy, which affects both normal and cancerous cells, targeted therapies more precisely target only cancer-related molecules. They also have cytostatic properties that stop tumor cells from growing and spreading rather than killing cells. Multiple targeted therapies have been approved to treat certain cancers, with more still in clinical trials.

1. What Are the Benefits of Target
Therapeutics for Cancer Patients?
By: Jay Zises

2. What Are the Benefits of Target Therapeutics for
Cancer Patients?
The chairman of A Cap, Inc., Jay Zises is a New York City-based financial executive who manages
investment portfolios for high-net worth individuals. Focused on securing seed money for young
entrepreneurs, Jay Zises stays up-to-date with emerging trends impacting his investment clients,
including developments in the field of targeted therapeutics.

3. What Are the Benefits of Target Therapeutics for
Cancer Patients?
A new tool in the field of anti-cancer drug development, targeted therapies are cutting-edge
pharmaceuticals that impede the growth of cancer by blocking specific molecules that promote
cancer cell growth. Also called “molecularly targeted drugs” or “precision medicines," targeted
therapies offer several benefits over standard chemotherapy.

4. What Are the Benefits of Target Therapeutics for
Cancer Patients?
While chemotherapy acts on rapidly dividing normal cells along with cancerous cells, targeted
therapies more precisely target only molecules associated with cancer. In addition, instead of using
the chemotherapy approach of killing cells, targeted therapeutics have cytostatic properties,
meaning they stop tumor cells from growing and spreading instead of killing them. The U.S. Food
and Drug Administration has already approved multiple targeted therapies for certain types of
cancer, while others are currently in the clinical trial stage.